Last updated on July 2019

A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE2)


Brief description of study

This is a Phase 3 multi-center, randomized, double-blind, vehicle-controlled, parallel group study to be conducted in up to approximately 340 subjects 6 months of age with MC. Subjects or their caregivers will apply SB206 12% or Vehicle Gel once daily for a minimum of 4 weeks and up to 12 weeks to all lesions identified at Baseline and new treatable lesions that arise during the course of the study.

Detailed Study Description

This is a Phase 3 multi-center, randomized, double-blind, vehicle-controlled, parallel group study to be conducted in approximately 340 subjects with MC. After obtaining informed consent/assent, subjects who satisfy entry criteria will be randomized 2:1 (active:vehicle). Subjects receiving current treatment for MC at the time of the Screening Visit will enter a wash out period of up to 14 days prior to randomization.

Subjects or their caregivers will apply SB206 12% or Vehicle Gel once daily for a minimum of 4 weeks and up to 12 weeks to all lesions identified at Baseline and new treatable lesions that arise during the course of the study. Subjects or their caregivers will continue to treat the area until the next scheduled visit even if the lesion(s) clear. If the investigator determines all lesions are cleared at a clinic visit, the treatment may stop. Subjects will visit the clinic at Screening/Baseline, Week 2, Week 4, Week 8, Week 12. In addition, subjects will be seen in the clinic for a safety follow-up at Week 24.

Clinical Study Identifier: NCT03927703

Find a site near you

Start Over

Site #266

Scottsdale, AZ United States
  Connect »

Site #101

Hot Springs, AR United States
  Connect »

Site #282

Beverly Hills, CA United States
  Connect »

Site #113

San Diego, CA United States
  Connect »

Site #257

Thornton, CO United States
  Connect »

Site #268

Boynton Beach, FL United States
  Connect »

Site #292

DeLand, FL United States
  Connect »

Site #278

Miami, FL United States
  Connect »

Site #305

Tampa, FL United States
  Connect »

Site #301

Columbus, GA United States
  Connect »

Site #175

New Albany, IN United States
  Connect »

Site #294

Owensboro, KY United States
  Connect »

Site #289

Metairie, LA United States
  Connect »

Site #297

New Orleans, LA United States
  Connect »

Site #275

Largo, MD United States
  Connect »

Site #274

Clarkston, MI United States
  Connect »

Site #121

Fridley, MN United States
  Connect »

Site #206

Omaha, NE United States
  Connect »

Site #304

Portsmouth, NH United States
  Connect »

Site #201

Berlin, NJ United States
  Connect »

Site #108

Rochester, NY United States
  Connect »

Site #309

Portland, OR United States
  Connect »

Site #255

Mount Pleasant, SC United States
  Connect »

Site #271

Knoxville, TN United States
  Connect »

Site #167

Houston, TX United States
  Connect »

Site #293

Plano, TX United States
  Connect »

Site #281

Syracuse, UT United States
  Connect »

Site #267

Richmond, VA United States
  Connect »